Gadolinium is a contrast agent used with MRI (Magnetic Resonance Imaging) and CT scans. It is also the preferred contrast agent for people with chronic kidney disease.
NSF or nephrogenic systemic fibrosis is an emerging systemic disorder characterized by widespread tissue fibrosis. Currently, little is known about NSF and there is no effective treatment available for it. However, recent studies found that NSF occurs only in patients with advanced or in end stage kidney disease and is strongly related to the use of gadolinium dyes for MRI scans. Hence, both the FDA and the company that makes gadodiamide have sent out warnings about the use of gadolinium.
Pending further research, experts are recommending that gadolinium-based MRI scans be avoided in patients with advanced kidney disease until more is known about the connection between gadolinium and NSF. For those interested, you can find more information about this topic by visiting the link in this post.
Great Article. There are more and more of these cases coming to light within the past few years.